Literature DB >> 28385819

Failure of fertility therapy and subsequent adverse cardiovascular events.

Jacob A Udell1, Hong Lu2, Donald A Redelmeier2.   

Abstract

BACKGROUND: Infertility may indicate an underlying predisposition toward premature cardiovascular disease, yet little is known about potential long-term cardiovascular events following fertility therapy. We investigated whether failure of fertility therapy is associated with subsequent adverse cardiovascular events.
METHODS: We performed a population-based cohort analysis of women who received gonadotropin-based fertility therapy between Apr. 1, 1993, and Mar. 31, 2011, distinguishing those who subsequently gave birth and those who did not. Using multivariable Poisson regression models, we estimated the relative rate ratio of adverse cardiovascular events associated with fertility therapy failure, accounting for age, year, baseline risk factors, health care history and number of fertility cycles. The primary outcome was subsequent treatment for nonfatal coronary ischemia, stroke, transient ischemic attack, heart failure or thromboembolism.
RESULTS: Of 28 442 women who received fertility therapy, 9349 (32.9%) subsequently gave birth and 19 093 (67.1%) did not. The median number of fertility treatments was 3 (interquartile range 1-5). We identified 2686 cardiovascular events over a median 8.4 years of follow-up. The annual rate of cardiovascular events was 19% higher among women who did not give birth after fertility therapy than among those who did (1.08 v. 0.91 per 100 patient-years, p < 0.001), equivalent to a 21% relative increase in the annual rate (95% confidence interval 13%-30%). We observed no association between event rates and number of treatment cycles.
INTERPRETATION: Fertility therapy failure was associated with an increased risk of long-term adverse cardiovascular events. These women merit surveillance for subsequent cardiovascular events.
© 2017 Canadian Medical Association or its licensors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28385819      PMCID: PMC5359104          DOI: 10.1503/cmaj.160744

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  40 in total

1.  Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?

Authors:  Alfredo M Germain; Mary Carmen Romanik; Irene Guerra; Sandra Solari; María Soledad Reyes; Richard J Johnson; Karen Price; S Ananth Karumanchi; Gloria Valdés
Journal:  Hypertension       Date:  2006-11-20       Impact factor: 10.190

Review 2.  Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.

Authors:  Ki Park; Janet Wei; Margo Minissian; C Noel Bairey Merz; Carl J Pepine
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

Review 3.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

Authors:  Leonardo Tamariz; Thomas Harkins; Vinit Nair
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

Review 4.  Clinical implications of the ovarian/endometrial renin-angiotensin-aldosterone system.

Authors:  E Hassan; G Creatsas; G Mastorakos; S Michalas
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10.

Authors:  Rae A Kokotailo; Michael D Hill
Journal:  Stroke       Date:  2005-07-14       Impact factor: 7.914

6.  Pregnancy loss and later risk of atherosclerotic disease.

Authors:  Mattis Flyvholm Ranthe; Elisabeth A Wreford Andersen; Jan Wohlfahrt; Henning Bundgaard; Mads Melbye; Heather A Boyd
Journal:  Circulation       Date:  2013-03-27       Impact factor: 29.690

7.  Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series.

Authors:  Hisao Ando; Kazunori Furugori; Daijiro Shibata; Toko Harata; Yasutaka Murata; Shigehiko Mizutani
Journal:  Hum Reprod       Date:  2003-06       Impact factor: 6.918

Review 8.  Ovarian hyperstimulation syndrome and complications of ART.

Authors:  Veerle Vloeberghs; Karen Peeraer; Anne Pexsters; Thomas D'Hooghe
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2009-07-25       Impact factor: 5.237

9.  Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation.

Authors:  Edgardo Somigliana; Fedro Alessandro Peccatori; Francesca Filippi; Fabio Martinelli; Francesco Raspagliesi; Ida Martinelli
Journal:  Hum Reprod Update       Date:  2014-07-10       Impact factor: 15.610

10.  Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women.

Authors:  Kobina A Wilmot; Martin O'Flaherty; Simon Capewell; Earl S Ford; Viola Vaccarino
Journal:  Circulation       Date:  2015-08-24       Impact factor: 29.690

View more
  13 in total

Review 1.  Sexual dysfunction and male infertility.

Authors:  Francesco Lotti; Mario Maggi
Journal:  Nat Rev Urol       Date:  2018-03-13       Impact factor: 14.432

2.  Protective placental inflammatory and oxidative stress responses are attenuated in the context of twin pregnancy and chorioamnionitis in assisted reproduction.

Authors:  Hayley R Price; Nick Pang; Hugh Kim; Michael W H Coughtrie; Abby C Collier
Journal:  J Assist Reprod Genet       Date:  2022-01-06       Impact factor: 3.412

Review 3.  Ischemic stroke and cerebral venous sinus thrombosis in pregnancy.

Authors:  Hannah J Roeder; Jean Rodriguez Lopez; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020

Review 4.  Stroke in Pregnancy: A Multidisciplinary Approach.

Authors:  Erica C Camargo; Aneesh B Singhal
Journal:  Obstet Gynecol Clin North Am       Date:  2021-03       Impact factor: 2.844

5.  Infertility and the Risk of Cardiovascular Disease: Findings From the Study of Women's Health Across the Nation (SWAN).

Authors:  Zoe F Cairncross; Sofia B Ahmed; Sandra M Dumanski; Kara A Nerenberg; Amy Metcalfe
Journal:  CJC Open       Date:  2020-11-24

6.  Assisted Reproductive Technology Outcomes in Women With Heart Disease.

Authors:  Mary M Quien; Anaïs Hausvater; Susan M Maxwell; Catherine R Weinberg
Journal:  Front Cardiovasc Med       Date:  2022-04-11

7.  Lifestyle and Comorbidities: Do We Take Enough Care of Preconception Health in Assisted Reproduction?

Authors:  Michela Cirillo; Maria Elisabetta Coccia; Cinzia Fatini
Journal:  J Family Reprod Health       Date:  2020-09

8.  Persistent organic pollutants and couple fecundability: a systematic review.

Authors:  Linda G Kahn; Kim G Harley; Eva L Siegel; Yeyi Zhu; Pam Factor-Litvak; Christina A Porucznik; Michele Klein-Fedyshin; Alison E Hipwell
Journal:  Hum Reprod Update       Date:  2021-02-19       Impact factor: 15.610

Review 9.  Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention.

Authors:  Petal Elder; Garima Sharma; Martha Gulati; Erin D Michos
Journal:  Am J Prev Cardiol       Date:  2020-06-06

Review 10.  Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all.

Authors:  Nanette Wenger
Journal:  Glob Cardiol Sci Pract       Date:  2017-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.